|
Pediatric
Pharmacy Conference Agenda
Special
Offering: Cystic
Fibrosis Pharmacist Boot Camp: October 1, 2008. You
must register seperately for this event.
Nutrition
Core Competencies for Pediatric Pharmacy Pre-Conference
10/02/08
10:00-10:40 am
Lines and Tube Access (180-000-08-100-L01-P)
Kathy Chessman, Pharm.D.
Professor of Clinical Pharmacy
South Carolina College of Pharmacy
By
the end of this presentation, participants will be able to:
TBA
10/02/08
10:40-11:20 am
Overview of Parental Nutrition in the Pediatric Patient (180-000-08-101-L01-P)
Kathleen Gura, Pharm.D.
Clinical Pharmacy Specialist in Gastroenterology & Nutrition,
Team Leader Surgical Programs
Children's Hospital Boston
By
the end of this presentation, participants will be able to:
1. List and discuss the common complications of PN.
2. Explain why neonates and infants require a specialized amino
acid solution when receiving PN.
3. Identify the indications and monitoring parameters for an infant
receiving PN.
10/02/08
11:20 am -12:00 pm
Enteral Nutrition (180-000-08-102-L01)
Christi Hall
By
the end of this presentations, participants will be able to:
TBD
Pediatric
Medication Safety Pre-Conference
10/2/08
1:10-2:00 pm
"First Do No Harm" - The Maryland Model Story (180-000-08-104-L05-P)
William F. Monogue, M.D., FACP
Executive Director & President
Maryland Patient Safety Center
By
the end of this presentation, participants will be able to:
1. Explain why patient safety is paramount in their daily activities.
2. Know the basic principals of how to reduce or eliminate errors.
3. Appreciate the concept of a "just culture" and why
it is central to safety improvement.
10/2/08
2:00-3:00 pm
Parenteral-related Medication Errors Involving Pediatric Patients
(180-000-08-105-L05-P)
John Santell, M.S., R.Ph., FASHP
Director, Educational Program Initiatives
U.S. Pharmacopeia
By
the end of this presentation, participants will be able to:
1. Identify the severity, types, and causes of parenteral medication
errors involving pediatric patients.
2. Identify and discuss the most frequently reported drug products
associated with harmful parenteral medication errors.
3. Highlight several examples of harmful parenteral-related medication
errors and outline common problems with such events.
10/2/08
3:15-4:15 pm
ISMP Initiatives (180-000-08-106-L05-P)
Stu Levine
By
the end of this presentation, participants will be able to:
TBD
10/02/08
5:00-6:30 pm Super Session: Keynote Address
A Parent's Story (180-000-08-107-L05-P)
Sorrell King
Sorrel
King founded the Josie King Foundation in 2001 with her husband
Tony after their daughter Josie died as a result of medical errors.
The Josie King Foundation supports innovative patient safety programs
that influence the way safety is incorporated into medical care.
The Josie King Pediatric Patient Safety Program and the Johns Hopkins
Hospital's Children's Center, the Condition H - Josie King Patient
Safety Call Line at UPMC - Shadyside Hospital, and Dr. Albert Wu's
work on disclosure training all received initial funding from the
Josie King Foundation and currently serve as models for patient
safety programs across the country.
Sorrel is a leading advocate for improving patient safety. As a
public speaker, she brings Josie's powerful story and the successes
of Foundation-sponsored safety initiatives to wide audiences to
ensure that what happened to Josie will never happen to another
patient.
The
Josie King Foundation's mission is to prevent others from dying
or being harmed by medical errors. By uniting healthcare providers
and consumers, and funding innovative safety programs, we hope to
create a culture of patient safety, together.
10/3/08 8:00-9:00 am
ASHP IV Safety Summit Discussion Briefing (180-000-08-109-L05-P)
Karl Gumpper, Pharm.D.
Director, Informatics Section
American Society of Health Systems Pharmacists
Cindy
Dusik, PharmD
Chair, Board of Directors
Pediatric Pharmacy Advocacy Group
At
the end of this session, participants will be able to:
TBD
10/03/08
9:00-10:00 am
Best Practice Awards (180-000-08-110-L04)
The
Impact of Pharmacist Credentialing on Therapeutic Drug Monitoring
Michael Chicella, PharmD
Children's Hospital of the King's Daughter, Norfolk, VA
Pharmacist-initiated
Medication Reconciliation in a Children's Hospital
Lauren E. Lasak-Temme, PharmD
UCSF Children's Hospital, San Francisco, CA
Development
of a Computerized Pediatric Anticoagulation Program
Elora Hilmas, PharmD
Alfred I. duPont Hospital for Children, Wilmington, DE
10/03/08
10:15-11:15 am
Pharmacotherapy for Congenital Heart Anomalies (180-000-08-111-L01-P)
Jaclyn Sawyer, Pharm.D.
Clinical Pharmacy Specialist - Cardiology
Cinicinnati Children's Hospital Medical Center
By
the end of this presentation, participants will be able to:
1. Provide pharmacologic management approaches to specific congenital
heart anomalies.
2. Describe the mechanism of various medications used in the management
of congenital heart anomalies.
3. Identify important monitoring parameters that are necessary for
these pharmaceutical interventions in such congenital heart anomalies.
10/03/08
11:15-12:15 pm
Antibiotic Stewardship (180-000-08-112-L01-P)
Talene Metjian , Pharm.D.
The Children’s Hospital of Philadelphia
Philadelphia, PA
By
the end of this presentation, participants will be able to:
1. Review the impact of antibiotic use and antibiotic resistance
2. Discuss the interventions to reduce antimicrobial resistance
3. Examine the evolution of the antimicrobial stewardship program
and its implementation in a pediatric hospital
10/03/08
10:15 am -12:15 pm
Research Workshop
Practical Statistics: How to Review and Interpret the Literature
(180-000-08-113-L04-P)
Allison Bernknopf, Pharm.D.
Associate Professor
Ferris State University
By
the end of this presentation, participants will be able to:
1. Define the basic conceptual concepts found within the article.
2. Determine if the appropriate study design and statistical analysis
was performed.
3. Describe the statistical and clinical significance of the article.
10/03/08
10:15 am -12:15 pm
Advocacy Workshop
How to be a parent advocate/Empowering Parents (180-000-08-114-L04-P)
Sherry Luedtke, PharmD
Associate Dean
Texas Tech University College of Pharmacy
At
the end of this presentation, participants will be able to:
TBD
10/03/08
10:15 am -12:15 pm
Teaching Workshop
ASHP PGY2 Specialty Residency (180-000-08-115-L04-P)
Lisa Lifshin, RPh
Director, Program Services; Coordinator, Technician Program Development
American Society of Health-System Pharmacists
By
the end of this presentation, participants will be able to:
1. Recognize the difference in standards between the PGY1 and PGY2
residency training programs.
2. Describe criteria for preceptorship in a PGY1 and PGY2 residency
training program.
3. Understand the importance of completing a PGY1 residency training
program prior to a PGY2 program.
10/03/08
12:15-2:00 pm
A Lunch Symposium Sponsored by Discovery Labs
Product
Quality of Pharmaceuticals Derived from Biologic Sources
David Hoff, Pharm.D.
Children's Hospitals and Clinics of Minnesota
Objectives:
1. Review the biologically derived products used in pediatrics and
the source materials.
2. Discuss the lot to lot consistency of active pharmaceutical ingredients
of biologically derived drugs.
3. Review issues regarding purity of pharmaceuticals derived from
biologic sources.
Patient
Care Issues of Biologically Derived Pharmaceuticals
Pirzada Sattar, M.D.
VA Hospital of Omaha, NE
Objectives:
1. Assess the potential for anaphylaxis and other potential adverse
experiences related to biologically derived products.
2. Discuss the ethical and religious issues regarding biologically
related products.
3. Review current and potential alternatives to biologically derived
products.
10/03/08 2:00-3:30 pm
Clinical Workshop
The Use of an Ethanol Lock in the Treatment and Prevention of Catheter-related
Infections in Children (180-000-08-117-L01-P)
Kathy Chessman, Pharm.D.
Professor of Clinical Pharmacy
South Carolina College of Pharmacy
By
the end of this presentation, participants will be able to:
1. Describe the pathogenesis and significance of catheter-related
infections (CRIs) in children, especially those with short bowel
syndrome.
2. Discuss outcomes associated with various 'lock' techniques used
to treat or prevent these CRIs in children.
3. State the potential benefits and risk of the use of an ethanol
lock in the treatment or prevention of CRIs.
10/03/08
2:00-3:30 pm
Clinical Workshop
Asthma Management: Intermediate (180-000-08-118-L01-P)
Leslie Briars, Pharm.D. & Heidi Smith-Hoopingarner, Pharm.D.
By
the end of this presentation, participants will be able to:
1. Discuss the updated 2007 National Asthma Education and Prevention
Program.
2. Provide practical tools for teaching asthma in the classroom
and to the patients.
3. Develop pharmaceutical plans for patient cases.
10/03/08
2:00-3:30 pm
Clinical Workshop
Diabetes Management: Individualized Insulin Management (180-000-08-119-L01-P)
Michelle Condren, Pharm.D. & Thomas Parker, Pharm.D.
By
the end of this presentation, participants will be able to:
1. Compare the advantages and disadvantages of various insulin regimens.
2. Determine patient-specific factors to consider when selecting
an insulin regimen.
3. Given a patient case, design an insulin regiment for a child
with Type 1 diabetes.
10/03/08
3:45-4:45 pm
Super Session: HPV- A Pro-Con Debate (180-000-08-120-L04-P)
By
the end of this presentation, participants will be able to:
TBD
10/03/08 6:00-7:45 pm
Satellite Symposium: Managing IV Stick Pain (180-000-08-121-L04-P)
Sponsored by: Anesiva
By
the end of this presentation, participants will be able to:
TBD
10/04/08
7:00-8:00 am
Top Infectious Diseases Articles/Clinical Pearls (180-000-08-122-L04-P)
By
the end of this presentation, participants will be able to:
TBD
10/04/08 1:00-2:00 pm
Richard A. Helms Excellence in Practice Award (180-000-08-124-L04-P)
Peter Gal, Pharm.D.
10/04/08 2:30-3:30 pm
Emergency Medicine (180-000-08-125-L04-P)
Shannon Manzi, Pharm.D.
ED Clinical Pharmacist/Team Leader
Children's Hospital Boston
By
the end of this presentation, participants will be able to:
1. Define the role of a pediatric ED pharmacist.
2. Describe three patient care initiatives that an ED pharmacist
can implement.
3. Discuss the ED pharmacist's role in at least 2 case based scenarios.
10/04/08
3:30-4:30 pm
Impact of USP 795 on Pediatric Pharmacy (180-000-08-126-L05-P)
Judith Thompson, B.S., M.S.
Clinical Associate Professor-Emeritus
Retired from University of Wisconsin-Madison School of Pharmacy
By
the end of this presentation, participants will be able to:
1. Identify the standards of practice given in USP Chapters <795>
Pharmaceutical Compounding - Nonsterile Preparations and <1075>
Good Compounding Practices.
2. List the <795> and <1075> recommended compounding
records and documents and describe their components.
3. Determine appropriate beyond-use dates for compounded preparations
based on guidelines in <795>.
10/04/08
2:30-4:30 pm
Research Workshop
Scholarship in a Practice/Clinical Setting (180-000-08-127-L04-P)
Tracy Hagemann, Pharm.D.
Associate Professor
University of Oklahoma College of Pharmacy
By
the end of this presentation, participants will be able to:
1. Identify opportunities for scholarship in your practice/setting.
2. Identify personnel whose involvement will be key in the success
of your scholarly project.
3. Design and map one potential project for your practice setting.
10/04/08
2:20-4:30 pm
PPAG Advocacy Workshop
The Role of the Pharmacists in Public Policy Debate (180-000-08-128-L03-P)
Joel Blackwell
Grassroots Advocacy Consultant
By
the end of this presentation, participants will be able to:
TBD
10/04/08
2:30-4:30 pm
Teaching Workshop
Generational Considerations for Learning and Teaching: Bridging
the Gap (180-000-08-129-L04-P)
Panel Discussion
By
the end of this presentation, participants will be able to:
10/05/08
7:00-8:00 am
Clinical Pearls (180-000-08-130-L04-P)
10/05/08
8:00-9:30 am
Clinical Workshop
The Use of an Ethanol Lock in the Treatment and Prevention of Catheter-related
Infections in Children (180-000-08-117-L01-P)
Kathy Chessman, Pharm.D.
Professor of Clinical Pharmacy
South Carolina College of Pharmacy
By
the end of this presentation, participants will be able to:
1. Describe the pathogenesis and significance of catheter-related
infections (CRIs) in children, especially those with short bowel
syndrome.
2. Discuss outcomes associated with various 'lock' techniques used
to treat or prevent these CRIs in children.
3. State the potential benefits and risk of the use of an ethanol
lock in the treatment or prevention of CRIs.
10/05/08
8:00-9:30 am
Clinical Workshop
Asthma Management Workshop: Advanced (180-000-08-131-L01-P)
Leslie Briars, Pharm.D. & Heidi Smith-Hoopingarner, Pharm.D.
By
the end of this presentation, participants will be able to:
1. Discuss the updated 2007 National Asthma Education and Prevention
Program.
2. Provide practical tools for teaching asthma in the classroom
and to the patients.
3. Develop pharmaceutical plans for patient cases.
10/05/08
8:00-9:30 am
Clinical Workshop
Diabetes Management: Individualized Insulin Management (180-000-08-119-L01-P)
Michelle Condren, Pharm.D. & Thomas Parker, Pharm.D.
By
the end of this presentation, participants will be able to:
1. Compare the advantages and disadvantages of various insulin regimens.
2. Determine patient-specific factors to consider when selecting
an insulin regimen.
3. Given a patient case, design an insulin regiment for a child
with Type 1 diabetes.
10/05/08
9:40-10:40 am
Medication and Breast Feeding: Current Concepts (180-000-08-132-L01-P)
Frank J. Nice, DPA, CPHP
IV Supervisor
NIH
By
the end of this presentation, participants will be able to:
1. Understand and apply current concepts regarding the use of medications
during breastfeeding.
2. Identify sources of information for medication use during breastfeeding.
3. Be able to counsel a mother who is breastfeeding and taking or
will take medications.
10/05/08
10:40-11:40 am
Donor Breast Milk: A Pro-Con Debate (180-000-08-133-L04-P)
Panel
By
the end of this presentation, participants will be able to:
TBD
|
